Imaging data on characterization of retinal autofluorescent lesions in a mouse model of juvenile neuronal ceroid lipofuscinosis (CLN3 disease)

被引:3
作者
Wang, Qing Jun [1 ,2 ]
Jung, Kyung Sik [1 ,3 ]
Mohan, Kabhilan [1 ,3 ]
Kleinman, Mark E. [1 ,3 ]
机构
[1] Univ Kentucky, Dept Ophthalmol & Visual Sci, Lexington, KY 40506 USA
[2] Univ Kentucky, Markey Canc Ctr, Lexington, KY 40506 USA
[3] East Tennessee State Univ, Dept Surg, Johnson City, TN USA
基金
美国国家卫生研究院;
关键词
Juvenile Neuronal Ceroid Lipofuscinosis; CLN3; vision loss; retinopathy; autofluorescent lesions; mitochondrial ATP synthase FO sub-complex subunit C; MITOCHONDRIAL ATP SYNTHASE; SUBUNIT-C; MUTATION; STORAGE; CELLS; GENE; MICE;
D O I
10.1016/j.dib.2020.106076
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Juvenile neuronal ceroid lipofuscinosis UNCL, aka. juvenile Batten disease or CLN3 disease), a lethal pediatric neurodegenerative disease without cure, often presents with vision impairment and characteristic ophthalmoscopic features including focal areas of hyper-autofluorescence. In the associated research article "Loss of CLN3, the gene mutated in juvenile neuronal ceroid lipofuscinosis, leads to metabolic impairment and autophagy induction in retinal pigment epithelium" (Zhong et al., 2020) [1], we reported ophthalmoscopic observations of focal autofluorescent lesions or puncta in the Cln3(Delta ex7/8) mouse retina at as young as 8 month old. In this data article, we performed differential interference contrast and confocal imaging analyses in all retinal layers to localize and characterize these autofluorescent lesions, including their spectral characteristics and morphology. We further studied colocalization of these autofluorescent lesions with the JNCL marker mitochondrial ATP synthase FO sub-complex subunit C and various established retinal cell type markers. (C) 2020 The Author(s). Published by Elsevier Inc.
引用
收藏
页数:10
相关论文
共 39 条
[21]   Protracted course of juvenile ceroid lipofuscinosis associated with a novel CLN3 mutation (p.Y199X) [J].
Sarpong, A. ;
Schottmann, G. ;
Ruether, K. ;
Stoltenburg, G. ;
Kohlschuetter, A. ;
Huebner, C. ;
Schuelke, M. .
CLINICAL GENETICS, 2009, 76 (01) :38-45
[22]   Synapse alterations precede neuronal damage and storage pathology in a human cerebral organoid model of CLN3-juvenile neuronal ceroid lipofuscinosis [J].
Gomez-Giro, Gemma ;
Arias-Fuenzalida, Jonathan ;
Jarazo, Javier ;
Zeuschner, Dagmar ;
Ali, Muhammad ;
Possemis, Nina ;
Bolognin, Silvia ;
Halder, Rashi ;
Jager, Christian ;
Kuper, Willemijn F. E. ;
van Hasselt, Peter M. ;
Zaehres, Holm ;
del Sol, Antonio ;
van der Putten, Herman ;
Scholer, Hans R. ;
Schwamborn, Jens C. .
ACTA NEUROPATHOLOGICA COMMUNICATIONS, 2019, 7 (01)
[23]   Intravitreal gene therapy preserves retinal function in a canine model of CLN2 neuronal ceroid lipofuscinosis [J].
Kick, Grace Robinson ;
Whiting, Rebecca E. H. ;
Ota-Kuroki, Juri ;
Castaner, Leilani J. ;
Morgan-Jack, Brandie ;
Sabol, Julianna C. ;
Meiman, Elizabeth J. ;
Ortiz, Francheska ;
Katz, Martin L. .
EXPERIMENTAL EYE RESEARCH, 2023, 226
[24]   Gene Therapy Targeting the Inner Retina Rescues the Retinal Phenotype in a Mouse Model of CLN3 Batten Disease [J].
Holthaus, Sophia-Martha Kleine ;
Aristorena, Mikel ;
Maswood, Ryea ;
Semenyuk, Olha ;
Hoke, Justin ;
Hare, Aura ;
Smith, Alexander J. ;
Mole, Sara E. ;
Ali, Robin R. .
HUMAN GENE THERAPY, 2020, 31 (13-14) :709-718
[25]   Mutational analysis of the feline CLN3 gene and an ultrastructural evaluation of lysosomal storage materials in a cat with neuronal ceroid lipofuscinosis: An investigation into the molecular basis of the disease [J].
Furusawa, Y. ;
Mizukami, K. ;
Yabuki, A. ;
Kuwamura, M. ;
Chang, H. S. ;
Hossain, M. A. ;
Rahman, M. M. ;
Uddin, M. M. ;
Mitani, S. ;
Yamato, O. .
VETERINARY JOURNAL, 2012, 194 (03) :425-428
[26]   Different early ER-stress responses in the CLN8mnd mouse model of neuronal ceroid lipofuscinosis [J].
Galizzi, Giacoma ;
Russo, Domenica ;
Deidda, Irene ;
Cascio, Caterina ;
Passantino, Rosa ;
Guarneri, Rosetta ;
Bigini, Paolo ;
Mennini, Tiziana ;
Drago, Gaspare ;
Guarneri, Patrizia .
NEUROSCIENCE LETTERS, 2011, 488 (03) :258-262
[27]   Pharmacological Effects on Ceroid Lipofuscin and Neuronal Structure in Cln3 a†ex7/8 Mouse Brain Cultures [J].
Brenneman, Douglas E. ;
Pearce, David A. ;
Kovacs, Attila ;
DeFrees, Shawn .
JOURNAL OF MOLECULAR NEUROSCIENCE, 2017, 63 (01) :100-114
[28]   A tailored Cln3Q352X mouse model for testing therapeutic interventions in CLN3 Batten disease [J].
Langin, Logan ;
Johnson, Tyler B. ;
Kovacs, Attila D. ;
Pearce, David A. ;
Weimer, Jill M. .
SCIENTIFIC REPORTS, 2020, 10 (01)
[29]   CRISPR/Cas9 mediated generation of an ovine model for infantile neuronal ceroid lipofuscinosis (CLN1 disease) [J].
Eaton, S. L. ;
Proudfoot, C. ;
Lillico, S. G. ;
Skehe, P. ;
Kline, R. A. ;
Hamer, K. ;
Rzechorzek, N. M. ;
Clutton, E. ;
Gregson, R. ;
King, T. ;
O'Neill, C. A. ;
Cooper, J. D. ;
Thompson, G. ;
Whitelaw, C. B. ;
Wishart, T. M. .
SCIENTIFIC REPORTS, 2019, 9 (1)
[30]   Finding the most appropriate mouse model of juvenile CLN3 (Batten) disease for therapeutic studies: the importance of genetic background and gender [J].
Kovacs, Attila D. ;
Pearce, David A. .
DISEASE MODELS & MECHANISMS, 2015, 8 (04) :351-361